A few months ago, the biotech company Moderna Inc. (NASDAQ: MRNA) drew investors’ attention by developing one of the most promising vaccines against COVID-19. Since
Investors regained caution in the face of a sharp increase in the number of coronavirus cases in the United States, where infections and hospitalizations now
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
